aldosterone has been researched along with allisartan isoproxil in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL | 1 |
1 other study(ies) available for aldosterone and allisartan isoproxil
Article | Year |
---|---|
Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Aortic Diseases; Biphenyl Compounds; Blood Pressure; Brain; Cerebrovascular Disorders; Heart; Hypertension; Imidazoles; Kaplan-Meier Estimate; Kidney; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Stroke | 2021 |